Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

cefditoren

cefditoren
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Spectracef TABLET, ORAL 200 mg, 400 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

NOTES

cefditoren (Spectracef)

  • 200 mg tablet q 12 hrs
  • 400 mg tablet q 12 hrs

cefpodoxime (Vantin)

  • 100 mg q 12 hrs
  • 200 mg q 12 hrs

 

For PEDS change to cefpodoxime weight based dose.

cefditoren (Spectracef) : cefpodoxime (Vantin)

                          2 mg : 1 mg

Updated: 24 May 2016 (Spectracef)

Last updated: Dec. 19, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved